EHS-COVID (376) How COVID-19 has fundamentally changed clinical research in global health

4 June, 2021

'The COVID-19 pandemic has not only re-emphasised the importance of well designed randomised clinical trials but also highlighted the need for large-scale clinical trials structured according to a master protocol in a coordinated and collaborative manner. There is also a need for structures and incentives to enable faster data sharing of anonymised datasets, and a need to provide similar opportunities to those in high-income countries for clinical trial research in low-resource regions where clinical trial research receives considerably less research funding.'

This is the conclusion of a paper in The Lancet Global Health, part of a new series on Clinical Trials in Global Health.

The paper is here:

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30542-8/fulltext

and here is the full series:

https://www.thelancet.com/series/clinical-trials-global-health

--

Neil Pakenham-Walsh, HIFA Coordinator, neil@hifa.org www.hifa.org